NRX Pharmaceuticals (NRXP) Restructuring Costs (2023 - 2026)
NRX Pharmaceuticals (NRXP) posted quarterly Restructuring Costs of -$6000.0 for Q1 2026, down 106.0% year-over-year from $100000.0 in Q1 2025, and down 120.0% quarter-over-quarter from $30000.0 in Q4 2025.
NRX Pharmaceuticals (NRXP) Restructuring Costs (2023 - 2026) Analysis & Trends
NRX Pharmaceuticals (NRXP) has reported Restructuring Costs for 4 consecutive years, with -$6000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Restructuring Costs fell 106.0% year-over-year to -$6000.0; the TTM figure through Mar 2026 stood at -$70000.0 (up 93.65% YoY), while the FY2025 annual figure was $36000.0, up 103.0% from the prior year.
- Restructuring Costs retreated to -$6000.0 in Q1 2026 per NRXP's latest filing, from $30000.0 in the prior quarter.
- Across five years, Restructuring Costs topped out at $250000.0 in Q2 2023 and bottomed at -$1.2 million in Q4 2024.
- Historically, Restructuring Costs has averaged -$117428.6 across 4 years, with a median of $30000.0 in 2025.
- Annual changes were most pronounced in 2025 — Restructuring Costs soared 102.5% — and 2026, when it plunged 106.0%.
- NRX Pharmaceuticals' Restructuring Costs stood at $250000.0 in 2023, then slumped by 580.8% to -$1.2 million in 2024, then jumped by 102.5% to $30000.0 in 2025, then slumped by 120.0% to -$6000.0 in 2026.
- Business Quant data shows NRXP's Restructuring Costs at -$6000.0 in Q1 2026, $30000.0 in Q4 2025, and -$94000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - |
| 10 | NRX Pharmaceuticals | 133.28 Mn | 106.58 Mn | 426,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6,000.00 |
| Dec 31, 2025 | 30,000.00 |
| Sep 30, 2025 | -94,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | -1.20 Mn |
| Jun 30, 2023 | 250,000.00 |
| Mar 31, 2023 | 100,000.00 |